Cargando…
Omalizumab is effective in nasal polyposis with or without asthma, a real-life study
BACKGROUND: Chronic rhinosinusitis with nasal polyposis (CRSwNP) can be recalcitrant in some patients despite medical therapies and surgery and has higher morbidity. Omalizumab is a new treatment option for patients with CRSwNP. The aim of this study is to evaluate the efficacy and safety of omalizu...
Autor principal: | Tat, Tuğba Songül |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382317/ https://www.ncbi.nlm.nih.gov/pubmed/36017064 http://dx.doi.org/10.1016/j.waojou.2022.100670 |
Ejemplares similares
-
A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics
por: Förster-Ruhrmann, Ulrike, et al.
Publicado: (2023) -
Clinical effectiveness and potential predictability of omalizumab in patients with difficult-to-treat chronic rhinosinusitis with nasal polyps and asthma based on the noninvasive markers – A real-life prospective study
por: Zheng, Ming, et al.
Publicado: (2022) -
Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China()
por: Wang, Ao, et al.
Publicado: (2022) -
Economic burden of severe asthma treatment: A real-life study()
por: López-Tiro, Jesús, et al.
Publicado: (2022) -
The impact of home treatment and self-administration of omalizumab on chronic urticaria
por: Wiuff, Anne Christine, et al.
Publicado: (2022)